In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples